From Google Scholar+ [to 13 July 2013]

From Google Scholar & other sources: Selected Journal Articles, Dissertations, Theses, Commentary

H7N9 Avian Influenza A Virus and the Perpetual Challenge of Potential Human Pandemicity
David M. Morensa, Jeffery K. Taubenbergerb, Anthony S. Faucia
mBio 4(4):e00445-13. doi:10.1128/mBio.00445-13.
Published 9 July 2013
http://mbio.asm.org/content/4/4/e00445-13
ABSTRACT
The ongoing H7N9 influenza epizootic in China once again presents us questions about the origin of pandemics and how to recognize them in early stages of development. Over the past ~135 years, H7 influenza viruses have neither caused pandemics nor been recognized as having undergone human adaptation. Yet several unusual properties of these viruses, including their poultry epizootic potential, mammalian adaptation, and atypical clinical syndromes in rarely infected humans, suggest that they may be different from other avian influenza viruses, thus questioning any assurance that the likelihood of human adaptation is low. At the same time, the H7N9 epizootic provides an opportunity to learn more about the mammalian/human adaptational capabilities of avian influenza viruses and challenges us to integrate virologic and public health research and surveillance at the animal-human interface.

A Comprehensive, Model-Based Review of Vaccine and Repeat Infection Trials for Filariasis
CP Morris, H Evans, SE Larsen, E Mitre – Clinical Microbiology Reviews, 2013
SUMMARY Filarial worms cause highly morbid diseases such as elephantiasis and river blindness. Since the 1940s, researchers have conducted vaccine trials in 27 different animal models of filariasis. Although no vaccine trial in a permissive model of filariasis has …

Vaccine adjuvants: the future is bright
R Rappuoli – Expert Review of Vaccines, 2013
Interview by Jenaid Rees, Commissioning Editor Rino Rappuoli is the Global Head of Vaccines Research at Novartis Vaccines & Diagnostics (Siena, Italy). Previously, he was Head of R&D (Sclavo, Italy), and then Head of Vaccine Research and Chief Scientific …

[PDF] Should acellular pertussis vaccine be recommended to healthcare professionals? A vacina pertússis acelular deve ser recomendada a profissionais de saúde?¿ La …
JC de Moraes, T Carvalhanas, LF Bricks – Cad. Saúde Pública, 2013
Page 1. Cad. Saúde Pública, Rio de Janeiro, 29(7):1277-1290, jul, 2013 Should acellular
pertussis vaccine be recommended to healthcare professionals? A vacina pertússis
acelular deve ser recomendada a profissionais de saúde? …

CURRENT OPINION Immunization in transplantation: review of the recent literature
LF Pittet, KM Posfay-Barbe – Curr Opin Organ Transplant, 2013
… CONCLUSION Despite an increasing number of interesting studies evaluating immunization in SOT patients, many questions remain unanswered and research should continue, aiming at elaborating the best immunization strategies in this vulnerable population. …